共 116 条
[1]
Shao Y(2011)Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead [J] BMC Public Health 11 110-798
[2]
Yang D(2017)The age-structured incidence and mortality of pulmonary tuberculosis reported in China, in 2005–15: a longitudinal analysis of national surveillance data [J] Lancet 390 S12-2064
[3]
Xu W(2015)Tuberculosis control in China: use of modelling to develop targets and policies [J] Bull World Health Organ 93 790-2170
[4]
Li J(2014)Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data [J] Lancet 383 2057-607
[5]
Li T(2012)National survey of drug-resistant tuberculosis in China [J] N Engl J Med 366 2161-245
[6]
Du X(2014)Mean platelet volume as an inflammation marker in active pulmonary tuberculosis [J] Multidiscip Respir Med 9 11-696
[7]
Lin HH(2005)Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis [J] Postgrad Med J 81 604-1302
[8]
Wang L(2007)The relation of serum interleukin-2 and C-reactive protein levels with clinical and radiological findings in patients with pulmonary tuberculosis [J] Tuberkuloz ve toraks 55 238-997
[9]
Zhang H(2015)The relationship between inflammatory marker levels and pulmonary tuberculosis severity [J] Inflammation 38 691-308
[10]
Wang L(2017)Entamoeba histolytica–encoded homolog of macrophage migration inhibitory factor contributes to mucosal inflammation during amebic colitis [J] J Infect Dis 215 1294-131